Phenylalanine improves dilation and blood pressure in GTP cyclohydrolase inhibition-induced hypertensive rats

Brett M. Mitchell, Anne M. Dorrance, R. Clinton Webb

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

GTP cyclohydrolase (GTPCH), the rate-limiting enzyme in the production of the nitric oxide synthase cofactor tetrahydrobiopterin (BH4), is partly regulated by the GTPCH feedback regulatory protein (GFRP). GFRP can inhibit GTPCH by end-product negative feedback, and L-phenylalanine (L-Phe) reverses this inhibition and increases BH4 biosynthesis in vitro. We hypothesized that L-Phe would increase endothelium-dependent relaxation and decrease blood pressure in rats made hypertensive by GTPCH inhibition. Diamino-hydroxy-pyrimidine (DAHP, 10 mmol/L), a known inhibitor of GTPCH, was given with or without L-Phe or D-Phe (2 mmol/L) in the drinking water of rats for 3 days and blood pressure was measured via tail-cuff. Endothelium-intact aortic segments were hung in organ chambers for measurement of isometric force generation. Systolic blood pressure was increased significantly in DAHP-treated rats compared with controls. The addition of L-Phe attenuated the hypertensive effect, whereas D-Phe had no effect. Acetylcholine- and A23187-induced relaxation was decreased in aortas from DAHP-treated rats compared with controls, but was restored in aortas from DAHP+L-Phe-treated rats. Following NOS inhibition, sensitivity to sodium nitroprusside was increased in aortas from DAHP-treated rats, but restored in DAHP+L-Phe-treated rats. These results suggest that L-Phe can reverse GTPCH inhibition in vivo leading to increased vasodilation and decreased blood pressure.

Original languageEnglish (US)
Pages (from-to)758-763
Number of pages6
JournalJournal of Cardiovascular Pharmacology
Volume43
Issue number6
DOIs
StatePublished - Jun 1 2004

Fingerprint

GTP Cyclohydrolase
Phenylalanine
Dilatation
Blood Pressure
Aorta
Endothelium
Calcimycin
Nitroprusside
Vasodilation
Nitric Oxide Synthase
Drinking Water
Acetylcholine
5-dehydro-3-deoxy-D-arabino-heptulosonic acid-7-phosphate
Tail
Proteins
Enzymes

Keywords

  • Experimental
  • GTP cyclohydrolase 1
  • GTP cyclohydrolase feedback regulatory protein
  • Hypertension
  • Nitric oxide synthase
  • Phenylalanine
  • Tetrahydrobiopterin

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Phenylalanine improves dilation and blood pressure in GTP cyclohydrolase inhibition-induced hypertensive rats. / Mitchell, Brett M.; Dorrance, Anne M.; Webb, R. Clinton.

In: Journal of Cardiovascular Pharmacology, Vol. 43, No. 6, 01.06.2004, p. 758-763.

Research output: Contribution to journalArticle

@article{01146f8af71e4a1893f3ad6dc7a489b1,
title = "Phenylalanine improves dilation and blood pressure in GTP cyclohydrolase inhibition-induced hypertensive rats",
abstract = "GTP cyclohydrolase (GTPCH), the rate-limiting enzyme in the production of the nitric oxide synthase cofactor tetrahydrobiopterin (BH4), is partly regulated by the GTPCH feedback regulatory protein (GFRP). GFRP can inhibit GTPCH by end-product negative feedback, and L-phenylalanine (L-Phe) reverses this inhibition and increases BH4 biosynthesis in vitro. We hypothesized that L-Phe would increase endothelium-dependent relaxation and decrease blood pressure in rats made hypertensive by GTPCH inhibition. Diamino-hydroxy-pyrimidine (DAHP, 10 mmol/L), a known inhibitor of GTPCH, was given with or without L-Phe or D-Phe (2 mmol/L) in the drinking water of rats for 3 days and blood pressure was measured via tail-cuff. Endothelium-intact aortic segments were hung in organ chambers for measurement of isometric force generation. Systolic blood pressure was increased significantly in DAHP-treated rats compared with controls. The addition of L-Phe attenuated the hypertensive effect, whereas D-Phe had no effect. Acetylcholine- and A23187-induced relaxation was decreased in aortas from DAHP-treated rats compared with controls, but was restored in aortas from DAHP+L-Phe-treated rats. Following NOS inhibition, sensitivity to sodium nitroprusside was increased in aortas from DAHP-treated rats, but restored in DAHP+L-Phe-treated rats. These results suggest that L-Phe can reverse GTPCH inhibition in vivo leading to increased vasodilation and decreased blood pressure.",
keywords = "Experimental, GTP cyclohydrolase 1, GTP cyclohydrolase feedback regulatory protein, Hypertension, Nitric oxide synthase, Phenylalanine, Tetrahydrobiopterin",
author = "Mitchell, {Brett M.} and Dorrance, {Anne M.} and Webb, {R. Clinton}",
year = "2004",
month = "6",
day = "1",
doi = "10.1097/00005344-200406000-00004",
language = "English (US)",
volume = "43",
pages = "758--763",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Phenylalanine improves dilation and blood pressure in GTP cyclohydrolase inhibition-induced hypertensive rats

AU - Mitchell, Brett M.

AU - Dorrance, Anne M.

AU - Webb, R. Clinton

PY - 2004/6/1

Y1 - 2004/6/1

N2 - GTP cyclohydrolase (GTPCH), the rate-limiting enzyme in the production of the nitric oxide synthase cofactor tetrahydrobiopterin (BH4), is partly regulated by the GTPCH feedback regulatory protein (GFRP). GFRP can inhibit GTPCH by end-product negative feedback, and L-phenylalanine (L-Phe) reverses this inhibition and increases BH4 biosynthesis in vitro. We hypothesized that L-Phe would increase endothelium-dependent relaxation and decrease blood pressure in rats made hypertensive by GTPCH inhibition. Diamino-hydroxy-pyrimidine (DAHP, 10 mmol/L), a known inhibitor of GTPCH, was given with or without L-Phe or D-Phe (2 mmol/L) in the drinking water of rats for 3 days and blood pressure was measured via tail-cuff. Endothelium-intact aortic segments were hung in organ chambers for measurement of isometric force generation. Systolic blood pressure was increased significantly in DAHP-treated rats compared with controls. The addition of L-Phe attenuated the hypertensive effect, whereas D-Phe had no effect. Acetylcholine- and A23187-induced relaxation was decreased in aortas from DAHP-treated rats compared with controls, but was restored in aortas from DAHP+L-Phe-treated rats. Following NOS inhibition, sensitivity to sodium nitroprusside was increased in aortas from DAHP-treated rats, but restored in DAHP+L-Phe-treated rats. These results suggest that L-Phe can reverse GTPCH inhibition in vivo leading to increased vasodilation and decreased blood pressure.

AB - GTP cyclohydrolase (GTPCH), the rate-limiting enzyme in the production of the nitric oxide synthase cofactor tetrahydrobiopterin (BH4), is partly regulated by the GTPCH feedback regulatory protein (GFRP). GFRP can inhibit GTPCH by end-product negative feedback, and L-phenylalanine (L-Phe) reverses this inhibition and increases BH4 biosynthesis in vitro. We hypothesized that L-Phe would increase endothelium-dependent relaxation and decrease blood pressure in rats made hypertensive by GTPCH inhibition. Diamino-hydroxy-pyrimidine (DAHP, 10 mmol/L), a known inhibitor of GTPCH, was given with or without L-Phe or D-Phe (2 mmol/L) in the drinking water of rats for 3 days and blood pressure was measured via tail-cuff. Endothelium-intact aortic segments were hung in organ chambers for measurement of isometric force generation. Systolic blood pressure was increased significantly in DAHP-treated rats compared with controls. The addition of L-Phe attenuated the hypertensive effect, whereas D-Phe had no effect. Acetylcholine- and A23187-induced relaxation was decreased in aortas from DAHP-treated rats compared with controls, but was restored in aortas from DAHP+L-Phe-treated rats. Following NOS inhibition, sensitivity to sodium nitroprusside was increased in aortas from DAHP-treated rats, but restored in DAHP+L-Phe-treated rats. These results suggest that L-Phe can reverse GTPCH inhibition in vivo leading to increased vasodilation and decreased blood pressure.

KW - Experimental

KW - GTP cyclohydrolase 1

KW - GTP cyclohydrolase feedback regulatory protein

KW - Hypertension

KW - Nitric oxide synthase

KW - Phenylalanine

KW - Tetrahydrobiopterin

UR - http://www.scopus.com/inward/record.url?scp=2542467793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542467793&partnerID=8YFLogxK

U2 - 10.1097/00005344-200406000-00004

DO - 10.1097/00005344-200406000-00004

M3 - Article

C2 - 15167268

AN - SCOPUS:2542467793

VL - 43

SP - 758

EP - 763

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 6

ER -